Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with ...

A consortium of medical groups are now recommending that most patients who are taking a GLP-1 weight-loss or diabetes drugs ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

Dr. John Sosa, a double board-certified expert in family and lifestyle medicine and the Chief Medical Officer for Drip Health ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 hours 44 min ago By Ewan Larkin - 4 hours 14 min ago By E.J. Schultz - 4 hours 14 min ago By Tim Nudd - 4 hours 14 min ago ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

Glucagon-like peptide medications that treat Type 2 diabetes and weight management continue to grow in popularity, though ...

“As anesthesiologists, we are committed to considering all factors to ensure patients get the best and safest care ... patients who are taking a GLP-1 weight-loss or diabetes drugs continue ...